Axogen Statistics
Total Valuation
Axogen has a market cap or net worth of $478.21 million. The enterprise value is $527.14 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Axogen has 45.54 million shares outstanding. The number of shares has increased by 3.96% in one year.
| Current Share Class | 45.54M |
| Shares Outstanding | 45.54M |
| Shares Change (YoY) | +3.96% |
| Shares Change (QoQ) | -5.95% |
| Owned by Insiders (%) | 1.68% |
| Owned by Institutions (%) | 86.05% |
| Float | 44.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 36.59 |
| PS Ratio | 2.14 |
| Forward PS | 2.09 |
| PB Ratio | 4.01 |
| P/TBV Ratio | 4.81 |
| P/FCF Ratio | 402.20 |
| P/OCF Ratio | 132.03 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 80.37, with an EV/FCF ratio of 443.35.
| EV / Earnings | n/a |
| EV / Sales | 2.71 |
| EV / EBITDA | 80.37 |
| EV / EBIT | n/a |
| EV / FCF | 443.35 |
Financial Position
The company has a current ratio of 4.28, with a Debt / Equity ratio of 0.67.
| Current Ratio | 4.28 |
| Quick Ratio | 2.22 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 6.44 |
| Debt / FCF | 59.71 |
| Interest Coverage | -0.05 |
Financial Efficiency
Return on equity (ROE) is -7.22% and return on invested capital (ROIC) is -0.14%.
| Return on Equity (ROE) | -7.22% |
| Return on Assets (ROA) | -0.13% |
| Return on Invested Capital (ROIC) | -0.14% |
| Return on Capital Employed (ROCE) | -0.22% |
| Revenue Per Employee | $430,354 |
| Profits Per Employee | -$15,847 |
| Employee Count | 452 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 1.59 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.00% in the last 52 weeks. The beta is 1.06, so Axogen's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | +40.00% |
| 50-Day Moving Average | 12.40 |
| 200-Day Moving Average | 15.00 |
| Relative Strength Index (RSI) | 44.68 |
| Average Volume (20 Days) | 624,977 |
Short Selling Information
The latest short interest is 2.27 million, so 4.98% of the outstanding shares have been sold short.
| Short Interest | 2.27M |
| Short Previous Month | 2.05M |
| Short % of Shares Out | 4.98% |
| Short % of Float | 5.07% |
| Short Ratio (days to cover) | 3.72 |
Income Statement
In the last 12 months, Axogen had revenue of $194.52 million and -$7.16 million in losses. Loss per share was -$0.16.
| Revenue | 194.52M |
| Gross Profit | 144.29M |
| Operating Income | -388,000 |
| Pretax Income | -16.54M |
| Net Income | -7.16M |
| EBITDA | 6.56M |
| EBIT | -388,000 |
| Loss Per Share | -$0.16 |
Full Income StatementBalance Sheet
The company has $22.07 million in cash and $71.00 million in debt, giving a net cash position of -$48.93 million or -$1.07 per share.
| Cash & Cash Equivalents | 22.07M |
| Total Debt | 71.00M |
| Net Cash | -48.93M |
| Net Cash Per Share | -$1.07 |
| Equity (Book Value) | 105.37M |
| Book Value Per Share | 2.32 |
| Working Capital | 71.33M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $3.62 million and capital expenditures -$2.43 million, giving a free cash flow of $1.19 million.
| Operating Cash Flow | 3.62M |
| Capital Expenditures | -2.43M |
| Free Cash Flow | 1.19M |
| FCF Per Share | $0.03 |
Full Cash Flow StatementMargins
Gross margin is 74.18%, with operating and profit margins of -0.20% and -3.68%.
| Gross Margin | 74.18% |
| Operating Margin | -0.20% |
| Pretax Margin | -3.68% |
| Profit Margin | -3.68% |
| EBITDA Margin | 3.37% |
| EBIT Margin | -0.20% |
| FCF Margin | 0.61% |
Dividends & Yields
Axogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.96% |
| Shareholder Yield | -3.96% |
| Earnings Yield | -1.50% |
| FCF Yield | 0.25% |
Dividend DetailsAnalyst Forecast
The average price target for Axogen is $23.83, which is 126.95% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23.83 |
| Price Target Difference | 126.95% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 16.31% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Axogen has an Altman Z-Score of 2.93 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.93 |
| Piotroski F-Score | 4 |